• 1
    Trudinger BJ, Giles WB, Cook CM, Bombardieri J, Collins L. Fetal umbilical artery flow velocity waveforms and placental resistance: clinical significance. Br J Obstet Gynaecol 1985;92: 2330.
  • 2
    Valcamonico A, Danti L, Frusca T, et al. Absent end-diastolic velocity in umbilical artery: risk of neonatal morbidity and brain damage. Am J Obstet Gynecol 1994;170: 796801.
  • 3
    Neilson JP, Alfirevic Z. Doppler ultrasound for fetal assessment in high risk pregnancies. Cochrane Pregnancy and Childbirth Group. Cochrane Database Syst Rev Issue 3, 2002
  • 4
    Wilcox AJ. Intrauterine growth retardation: beyond birthweight criteria. Early Hum Dev 1983;8: 189193.
  • 5
    Secher NJ, Lundbye-Christensen S, Qvist I, Bagger P. An evaluation of clinical estimation of fetal weight and symphysis fundal distance for detection of SGA infants. Eur J Obstet Gynecol Reprod Biol 1991;38: 9196.
  • 6
    Rosenberg K, Grant JM, Tweedy I, Aitchison T. Measurement of fundal height as a screening test for intrauterine growth retardation. Br J Obstet Gynaecol 1982;89: 1215.
  • 7
    Calvert JP, Crean EE, Newcombe RG, Pearson JF. Antenatal screening by measurement of symphysis-fundus height. BMJ 1982;285: 846849.
  • 8
    Ounsted M, Moar V, Scott WA. Perinatal morbidity and mortality in small-for-dates babies: the relative importance of some maternal factors. Early Hum Dev 1981;5: 367369.
  • 9
    Burke G, Stuart B, Crowley P, Ni Scanaill S, Drumm J. Is intrauterine growth retardation with normal umbilical artery blood flow a benign condition?. BMJ 1990;300: 10441045.
  • 10
    Thompson RS, Trudinger BJ, Cook CM. Doppler ultrasound waveform indices: AB ratio, pulsatility index and Pourcelot ratio. Br J Obstet Gynaecol 1988;85: 581588.
  • 11
    Bricker L, Neilson JP. Routine Doppler ultrasound in pregnancy. Cochrane Pregnancy and Childbirth Group. Cochrane Database Syst Rev, Issue 3, 2002
  • 12
    Herschkovitz R, Kingdom JCP, Geary M, Rodeck CH. Fetal cerebral blood flow redistribution in late gestation: identification of compromise in small fetuses with normal umbilical artery Doppler. Ultrasound Obstet Gynecol 2000;15: 209212.
  • 13
    McCowan LME, Harding JE, Stewart AW. Umbilical artery Doppler studies in small for gestational age babies reflect disease severity. Br J Obstet Gynaecol 2000;107: 916925.
  • 14
    Massague J. The transforming growth factor beta family. Annu Rev Cell Biol 1990;6: 597641.
  • 15
    Wallace EM, Healy DL. Inhibins and activins: roles in clinical practice. Br J Obstet Gynaecol 1996;103: 945956.
  • 16
    Tong S, Wallace EM, Burger HG. Inhibins and activins: clinical advances in reproductive medicine. Clin Endocrinol (Oxf), 2003. In press.
  • 17
    Fowler PA, Evans LW, Groome NP, Templeton A, Knight PG. A longitudinal study of maternal serum inhibin A, inhibin B, activin A, activin AB, pro-αC and follistatin during pregnancy. Hum Reprod 1998;13: 35303536.
  • 18
    Schneider-Kolsky M, D'Antona D, Evans LW, et al. Maternal serum total activin A and follistatin in pregnancy and parturition. Br J Obstet Gynaecol 2000;107: 9951000.
  • 19
    Jenkin G, Ward J, Hooper SB, O'Conner AE, de Kretser D, Wallace EM. Feto-placental hypoxaemia regulates the release of fetal activin A and prostaglandin E2. Endocrinology 2001;142: 963966.
  • 20
    Muttukrishna S, Knight PG, Groome NP, Redman CWG, Ledger WL. Activin A and inhibin A as possible endocrine markers for preeclampsia. Lancet 1997;349: 12851288.
  • 21
    Schneider-Kolsky ME, Tong S, Wallace EM. Maternal and fetal activin A levels: associations with normal and abnormal labour. Placenta 2002;23: 542546.
  • 22
    Kingdom J, Smith G. Diagnosis and management of IUGR. In: KingdomJ, BakerP editors. Intrauterine Growth Restriction. Aetiology and Management. London : Springer-Verlag, 2000: 257274
  • 23
    Brown MA, Hague WM, Higgins J, et al. The detection, investigation and management of hypertension in pregnancy: full consensus statement. Aust N Z J Obstet Gynaecol 2000;40: 139155.
  • 24
    Knight PG, Muttukrishna S, Groome NP. Development and application of a two-site enzyme immunoassay for the determination of total activin A-concentrations in serum and follicular fluid. J Endocrinol 1996;148: 267279.
  • 25
    Riley SC, Balfour CM, Wathen N, et al. Follistatin and activin A in extra-embryonic coelomic and amniotic fluids and maternal serum in early pregnancy. Hum Reprod 1998;13: 26242628.
  • 26
    Roberts CL, Lancaster PA. Australian national birthweight percentiles by gestational age. Med J Aust 1999;170: 114118.
  • 27
    Silver HM, Lambert-Messerlian GM, Star JA, Hogan J, Canick JA. Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies. Am J Obstet Gynecol 1999;180: 11311137.
  • 28
    D'Antona D, Reis FM, Benedetto C, et al. Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders. J Endocrinol 2000;165: 157162.
  • 29
    Keelan JA, Taylor R, Schellenberg JC, Groome NP, Mitchell MD, North RA. Serum activin A, inhibin A and follistatin concentrations in preeclampsia or small for gestational age pregnancies. Obstet Gynecol 2002;99: 267274.
  • 30
    Muttukrishna S, North RA, Morris J, et al. Serum inhibin A and activin A are elevated prior to the onset of preeclampsia. Hum Reprod 2000;15: 16401645.
  • 31
    Manuelpillai U, Schneider-Kolsky M, Dole A, Wallace EM. Activin A and activin receptors in gestational tissue from preeclamptic pregnancies. J Endocrinol 2001;171: 5764.
  • 32
    Bobrow CS, Holmes RP, Muttukrishna S, et al. Maternal serum activin A, inhibin A, and follistatin in pregnancies with appropriately grown and small-for-gestational-age fetuses classified by umbilical artery Doppler ultrasound. Am J Obstet Gynecol 2002;186: 283287.
  • 33
    Chang TC, Robson SC, Spencer JA, Gallivan S. Prediction of perinatal morbidity at term in small fetuses: comparison of fetal growth and Doppler ultrasound. Br J Obstet Gynaecol 1994;101: 422427.
  • 34
    Stanley F, Blair E, Alberman E. Pathways to cerebral palsy involving intrauterine growth restriction. In: StanleyF, BlairE, Alberman editors Cerebral Palsies: Epidemiology and Causal Pathways. London : Mac Keith Press, 2000: 8397
  • 35
    Bobrow CS, Soothill PW. Fetal growth velocity: a cautionary tale. Lancet 1999;168: 547555.
  • 36
    Florio P, Benedetto C, Luisi S, et al. Activin A, inhibin A and parturition: changes of maternal and cord serum levels according to the mode of delivery. Br J Obstet Gynaecol 1999;106: 10611065.